Page last updated: 2024-08-22

triamcinolone hexacetonide and osteoprotegerin

triamcinolone hexacetonide has been researched along with osteoprotegerin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
af Klint, E; Botusan, IR; Catrina, AI; Catrina, SB; Klareskog, E; Klareskog, L; Makrygiannakis, D; Ulfgren, AK	1

Other Studies

1 other study(ies) available for triamcinolone hexacetonide and osteoprotegerin

Article	Year
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. Arthritis and rheumatism, 2006, Volume: 54, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis; Carrier Proteins; Cells, Cultured; Female; Glycoproteins; Humans; Injections, Intra-Articular; Male; Membrane Glycoproteins; Middle Aged; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Synovial Membrane; Triamcinolone Acetonide	2006

Article

Year

Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.

Arthritis and rheumatism, 2006, Volume: 54, Issue:5

Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis; Carrier Proteins; Cells, Cultured; Female; Glycoproteins; Humans; Injections, Intra-Articular; Male; Membrane Glycoproteins; Middle Aged; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Synovial Membrane; Triamcinolone Acetonide

2006